Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

This article updates the Heart Failure Association of the European Society of Cardiology
(ESC) 2007 classification of advanced heart failure and describes new diagnostic and …

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Aim This study aimed to assess safety and outcomes of patients, 2 years after implantation
with the HeartMate 3 Left Ventricular Assist System. Methods and results This study included …

Abstract Aims The ELEVATE Registry was designed to study long-term outcomes with the
Heartmate 3 (HM3), a fully magnetically levitated centrifugal ventricular assist device, in a …

Aims Left ventricular assist device (LVAD) therapy improves the haemodynamics of
advanced heart failure patients. However, it is unknown whether haemodynamic …

Abstract Treatment strategies to combat cardiogenic shock (CS) have remained stagnant
over the past decade. Mortality rates among patients who suffer CS after acute myocardial …

Aims The ELEVATE registry was planned to study post-approval outcomes with HeartMate
3™(HM3), a fully magnetically levitated continuous flow left ventricular assist device (LVAD) …

Significant right ventricular failure accompanying left ventricular failure was treated by
implantation of the fully magnetically levitated centrifugal HeartMate 3 ventricular assist …